Novartis AG (NVS)
94.41
+0.89
(+0.95%)
USD |
NYSE |
Apr 15, 16:00
94.99
+0.58
(+0.61%)
Pre-Market: 20:00
Novartis Payables and Accrued Expenses (Quarterly)
Payables and Accrued Expenses (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Payables and Accrued Expenses (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| Date | Value |
|---|---|
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| September 30, 2016 | -- |
| June 30, 2016 | -- |
| March 31, 2016 | -- |
| December 31, 2015 | -- |
| September 30, 2015 | -- |
| June 30, 2015 | -- |
| March 31, 2015 | -- |
| December 31, 2014 | -- |
| September 30, 2014 | -- |
| June 30, 2014 | -- |
| March 31, 2014 | -- |
| December 31, 2013 | -- |
| September 30, 2013 | -- |
| June 30, 2013 | -- |
| March 31, 2013 | -- |
| December 31, 2012 | -- |
| September 30, 2012 | -- |
| June 30, 2012 | -- |
| March 31, 2012 | -- |
| December 31, 2011 | -- |
| September 30, 2011 | -- |